- Home
- LI vs ILMN Comparison
LI vs ILMN Comparison
Compare LI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | ILMN |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 26.7B |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LI | ILMN |
|---|---|---|
| Price | $12.12 | $188.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 17 |
| Target Price | $19.66 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 2.9M | 1.9M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.87 |
| EPS | N/A | ★ 2.22 |
| Revenue | N/A | ★ $4,343,000,000.00 |
| Revenue This Year | $18.98 | $6.47 |
| Revenue Next Year | $22.72 | $5.58 |
| P/E Ratio | ★ $29.50 | $87.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.65 | $88.00 |
| 52 Week High | $26.94 | $207.00 |
Technical Indicators
Market Signals| Indicator | LI | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 47.73 |
| Support Level | $12.06 | $186.64 |
| Resistance Level | $12.39 | $196.66 |
| Average True Range (ATR) | 0.24 | 7.45 |
| MACD | -0.06 | -1.63 |
| Stochastic Oscillator | 0.89 | 10.85 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.